-
A federal judge ordered the Trump administration on Thursday to temporarily restore access to CNN, MS NOW and Politico, after they were banned from covering White House events by President Trump.
-
Venezuela's acting president, delivering her first address to the U.N. General Assembly since coming to power, promised elections and said the nation's people will determine the "right moment."
-
Prime Minister Anthony Albanese said he was extremely concerned about OpenAI 's breach of an Australian health department website that the artificial intelligence company took too long to reveal.
-
Fears are growing of a return to war in Ethiopia's Tigray region, just four years after a devastating conflict ended in a fragile peace deal.
-
Southwestern Mexico braced for heavy rain and mudslides after Polo became a major hurricane. Forecasters warned another system headed for Hawaii could cause catastrophic flooding later in the week.
-
Lawyers representing the White House and the three media outlets banned from the property sparred over the constitutional rights of journalists at a hearing in federal court Wednesday.
It is the second time the leaders are meeting this year after the Beijing summit in May.
-
Housing affordability challenges are spreading to higher income brackets, according to new research, which found one in five renters struggled last year to pay for their housing in full and on time.
-
For anyone who grew up staring blankly at museum artwork, this is the fun that was missing: Coco leads interactive and (mostly) factual art history comedy tours.
-
Building dams and hydropower plants in the Himalayas holds great promise for providing electricity. In the wake of the Nepal disaster, experts are asking about the risks of such construction.
-
Deals, threats and oil are all on the table as the president's foreign policy takes center stage.
-
The company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of experts weighed the evidence and decided to cautiously recommend it for FDA approval.